Synonyms ATLL, ATLV関連白血病-リンパ腫, ATLV関連白血病リンパ腫 + [146] |
Introduction Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. |
Target |
Mechanism EZH1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date26 Sep 2022 |
Target |
Mechanism HDAC inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date23 Feb 2015 |
Target |
Mechanism HDAC inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date23 Dec 2014 |
Start Date01 Jul 2024 |
Sponsor / Collaborator- |
Start Date07 Feb 2024 |
Sponsor / Collaborator |
Start Date30 Nov 2023 |
Sponsor / Collaborator |